Day: August 6, 2024

Advanced MYCHELANGELO™ I trial; Company expects to select recommended dose for expansion and initiate monotherapy and combination expansion cohorts in fourth quarter of 2024 Reinforced diverse capabilities of the OMEGA platform at scientific meetings, including demonstration of precise and durable upregulation of gene expression Strengthened leadership team with appointment of Kaan Certel, Ph.D., as Chief Business Officer and election of Richard N. Kender to Board of DirectorsCAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced financial results for the second quarter ended June 30, 2024, and highlighted recent Company progress. “We...

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) — Evergold Corp. (TSXV: EVER, WKN: A2PTHZ) (“Evergold” or the “Company”) is pleased to report that personnel have been active on the ground at the Company’s road-accessible DEM1 precious and strategic metals discovery in central B.C., refining targets and preparing for the fall drill program, which the Company is now fully financed to complete. “Geophysical surveying earlier this year (see news, May 13, 2024) highlighted an exceptionally strong target lying between last year’s two widely spaced drill pads, with another emerging to the south, suggesting that our first-ever holes on the large DEM1 target may have just missed where we really need to be,” said Kevin Keough, President and CEO. “Testing these targets will be the primary focus for the forthcoming September-October drill program,...

QUEBEC CITY, Canada, Aug. 06, 2024 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVision™, for ADAS, AD and parking applications, announces it entered into an Eleventh Amending Agreement (the “Amendment and Waiver”) with Fédération des caisses Desjardins du Québec (“Desjardins”) with respect to the Amended and Restated Financing Offer dated as of April 5, 2023 (as amended, the “Desjardins Credit Facility”). As previously announced by the Company on July 5, 2024, pursuant to a Ninth Amending Agreement to the Desjardins Credit Facility, the Company was required to maintain an unencumbered cash balance (the “Minimum Cash Covenant”) of C$3.5...

VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or “the Company”) advises that the British Columbia Securities Commission has notified the Company that it has issued a cease trade order (“FFCTO”) under Multilateral Instrument 11-103 – Failure-to-File Cease Trade Orders in Multiple Jurisdictions for the Company. The FFCTO was issued as a result of the Company’s delay in filing its audited annual financial statements, accompanying management discussion and analysis, and CEO and CFO certifications for the financial year ended March 31, 2024 (the “Annual Filings”) in accordance with applicable Canadian securities laws. The FFCTO prohibits any trading, whether direct or indirect, in respect of each security of the Company in each jurisdiction in Canada until such time as the...

Beamr Issues Q2-2024 CEO Letter to Shareholders and Announces its First Half 2024 Financial Results Herzliya, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer, including its financial results for the six months ended June 30, 2024. Dear Shareholders: I am pleased to update you on our Q2-2024 activities and progress, which include significant developments in Beamr Cloud video services, Beamr product enhancements and collaborations with industry giants. These developments span the integration of artificial intelligence (AI) features into Beamr Cloud, an improved pricing model for our products and demonstrations at industry premier events, including optimization of real-time...

VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (TSXV: NWST) (“NorthWest” or the “Company”) is pleased to announce that it has published its annual Environmental, Social and Governance Report (“ESG Report”) for the period ended December 31, 2023. The ESG Report and Scorecard can be found at:https://northwestcopper.ca/investors/esg-reports/ https://www.onyen.com/published/NWC_2023_Annual_729.htmlMaryantonett Flumian, NorthWest Copper’s Chair, stated “As NorthWest Copper continues to create value through exploration at our portfolio of projects in British Columbia, we know that an integral part of creating long-term value is ensuring we have a sound foundation of ESG practices and initiatives in place. This is why the Company will remain focused on continually improving its responsible, sustainable...

LONDON and NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announced today the grant of a key European Patent entitled: “Compositions Comprising Chemerin Analogs and Methods of Use”. The present disclosure that lists Raj Patil, Chief Scientific Officer of OKYO Pharma as a joint Inventor, relates to novel OK-101 chemerin analogs for use in treating various diseases and conditions including but not limited to, ocular inflammatory and pain conditions, strengthening the Company’s...